Institutional shares held 19 Million
41.4K calls
49.2K puts
Total value of holdings $87.3M
$190K calls
$226K puts
Market Cap $244M
52,950,000 Shares Out.
Institutional ownership 35.83%
# of Institutions 58


Latest Institutional Activity in ENOB

Top Purchases

Q1 2025
Rhumbline Advisers Shares Held: 123K ($566K)
Q1 2025
Amalgamated Bank Shares Held: 3.99K ($18.4K)
Q4 2024
Geode Capital Management, LLC Shares Held: 2.33M ($10.7M)
Q4 2024
State Street Corp Shares Held: 2.06M ($9.5M)
Q4 2024
Ubs Group Ag Shares Held: 764K ($3.51M)

Top Sells

Q1 2025
Sg Americas Securities, LLC Shares Held: 37.1K ($171K)
Q4 2024
Hsbc Holdings PLC Shares Held: 13.5K ($62K)
Q4 2024
New York State Common Retirement Fund Shares Held: 52.5K ($241K)
Q4 2024
Jane Street Group, LLC Shares Held: 10.3K ($47.5K)
Q4 2024
Xtx Topco LTD Shares Held: 10.1K ($46.6K)

About ENOB

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.


Insider Transactions at ENOB

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
500K Shares
From 2 Insiders
Grant, award, or other acquisition 500K shares
Sell / Disposition
5.51M Shares
From 4 Insiders
Other acquisition or disposition 4.2M shares
Open market or private sale 473K shares
Sale (or disposition) back to the issuer 833K shares

Track Institutional and Insider Activities on ENOB

Follow Enochian Biosciences Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENOB shares.

Notify only if
Any

Insider Trading

Get notified when an Enochian Biosciences Inc insider buys or sells ENOB shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Enochian Biosciences Inc

Track Activities on ENOB